ZURLO, MARCO
ZURLO, MARCO
Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation
2025-01-01 Cheema, Naila Arif; Castagna, Annalisa; Ambrosani, Francesca; Argentino, Giuseppe; Friso, Simonetta; Zurlo, Marco; Beri, Ruggero; Maule, Matteo; Vaia, Rachele; Senna, Gianenrico; Caminati, Marco
Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations
2026-01-01 Caminati, Marco; Gagliani, Claudia; Bondi, Benedetta; Bagnasco, Diego; Vijverberg, Susanne J. H.; Zurlo, Marco; Maule, Matteo; Principe, Stefania
Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation
2025-01-01 Caminati, Marco; Zurlo, Marco; Guida, Giuseppe; Bertolini, Francesca; Levra, Stefano; Maule, Matteo; Ricciardolo, Fabio Luigi Massimo; Vultaggio, Alessandra
Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups
2026-01-01 Zurlo, Marco; Ambrosani, Francesca; Maule, Matteo; Cheema, Naila Arif; Mascia, Francesca; Aparo, Antonino; Argentino, Giuseppe; Vaia, Rachele; Baiocchi, Anna; Senna, Gianenrico; Friso, Simonetta; Castagna, Annalisa; Caminati, Marco
Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective
2026-01-01 Caminati, M; Mastrototaro, A; Maule, M; Schiappoli, M; Vaia, R; Zurlo, M; Bini, F; Brussino, L; D'Amato, M; Marra, A M; Nicola, S; Schroeder, J W V; Senna, G; Benoni, R
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications
2026-01-01 Caminati, Marco; Portacci, Andrea; Cefaloni, Francesca; Loperfido, Antonella; Maule, Matteo; Zurlo, Marco; Montuori, Claudio; D'Auria, Leandro Maria; Schiappoli, Michele; Carpagnano, Giovanna Elisiana; De Corso, Eugenio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation | 1-gen-2025 | Cheema, Naila Arif; Castagna, Annalisa; Ambrosani, Francesca; Argentino, Giuseppe; Friso, Simonetta; Zurlo, Marco; Beri, Ruggero; Maule, Matteo; Vaia, Rachele; Senna, Gianenrico; Caminati, Marco | |
| Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations | 1-gen-2026 | Caminati, Marco; Gagliani, Claudia; Bondi, Benedetta; Bagnasco, Diego; Vijverberg, Susanne J. H.; Zurlo, Marco; Maule, Matteo; Principe, Stefania | |
| Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation | 1-gen-2025 | Caminati, Marco; Zurlo, Marco; Guida, Giuseppe; Bertolini, Francesca; Levra, Stefano; Maule, Matteo; Ricciardolo, Fabio Luigi Massimo; Vultaggio, Alessandra | |
| Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups | 1-gen-2026 | Zurlo, Marco; Ambrosani, Francesca; Maule, Matteo; Cheema, Naila Arif; Mascia, Francesca; Aparo, Antonino; Argentino, Giuseppe; Vaia, Rachele; Baiocchi, Anna; Senna, Gianenrico; Friso, Simonetta; Castagna, Annalisa; Caminati, Marco | |
| Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective | 1-gen-2026 | Caminati, M; Mastrototaro, A; Maule, M; Schiappoli, M; Vaia, R; Zurlo, M; Bini, F; Brussino, L; D'Amato, M; Marra, A M; Nicola, S; Schroeder, J W V; Senna, G; Benoni, R | |
| When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications | 1-gen-2026 | Caminati, Marco; Portacci, Andrea; Cefaloni, Francesca; Loperfido, Antonella; Maule, Matteo; Zurlo, Marco; Montuori, Claudio; D'Auria, Leandro Maria; Schiappoli, Michele; Carpagnano, Giovanna Elisiana; De Corso, Eugenio |